Skip to content

Hip arthritis review finds no clear advantage for high molecular weight hyaluronic acid

Across a small group of randomized trials, this form of hyaluronic acid did not significantly outperform the comparison treatments on pain or measures of function.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

For people with hip osteoarthritis, the pooled evidence did not show a statistically significant advantage for high molecular weight hyaluronic acid over the therapies it was compared with. Pain, stiffness, physical function and overall patient ratings showed no clear between-group differences. Wide uncertainty around the estimates means these results do not prove that the treatments work equally well.

Keep in mind

This abstract-based account lacks follow-up durations and detailed trial methods. Although safety was part of the review’s aim, the abstract provides no adverse-event results, so it cannot establish comparative safety.

Several outcomes were assessed

The review combined trials comparing this form of hyaluronic acid with several alternatives. Researchers examined pain alongside joint-specific symptom and function scores, as well as patients’ overall assessments; none showed a statistically clear advantage.

Uncertainty remains substantial

The reported confidence intervals allowed for effects on either side of no difference. A nonsignificant result therefore leaves room for potentially different outcomes and should not be interpreted as proof of equal effectiveness.

CHECK THE ORIGINAL

The original publication

Viscosupplementation with High Molecular Weight Hyaluronic Acid for Hip Osteoarthritis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Pasqualotto T, Pasqualotto E, Migliardi LS et al.
Rev Bras Ortop (Sao Paulo) · 2026

PubMed ID
42038512
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.